Indikation zur radikalen Prostatektomie — Wann?

Albertsen P, Fryback D, Storer B, Kolon T, Fine J (1995) Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274: 626–631 Aus G, Hugosson J, Norlen L (1995) Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol 154: 460–465 Boxer RJ, Kaufman JJ, Goodwin WE (1977) Radical prostatectomy for carcinoma of the prostate: 1951–1976. A review of 329 patients. J Urol 117: 208–213 Carter HB, Sauvageot J, Walsh PC, Epstein JI (1997) Prospective evaluation of men with stage T1c adenocarcinoma of the prostate. J Urol 157: 2206–2209 Catalona WJ, Smith DS (1994) 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152: 1837–1842 Catalona WJ, Stein AJ, Fair WR (1982) Grading errors in prostatic needle biopsies: relation to the accuracy of tumor grade in predicting pelvic lymph node metastases. J Urol 127: 919–922 Corral DA, Bahnson RR (1994) Survival of men with clinically localized prostate cancer detected in the eight decade of life. J Urol 151: 1326–1329 Davidson PJT, Van den Ouden D, Schroeder FH (1996) Radical prostatectomy: prospective assessment of mortality and morbidity. Eur Urol 29: 168–173 Flanigan RC, McKay TC, Olson M, Shankey TV, Pyle J, Waters WB (1996) Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Urology 48: 428–432 Frohmüller H, Theiß M, Wirth M, Hofmockel G (1995) 15-Jahres Ergebnisse der radikalen Prostatektomie. Urologe [A] 34: 225–230 Frohmüller H, Theiss M, Wirth MP (1991) Radical prostatectomy for carcinoma of the prostate: long-term follow up of 115 patients. Eur Urol 19: 279–283 Gaker DL, Gaker LB, Steward JF, Gillenwater JY (1996) Radical prostatectomy with preservation of urinary continence. J Urol 156: 445–449 Geary ES, Dendinger TE, Freiha FS, Stamey TA (1995) Nerve sparing radical prostatectomy: a different view. J Urol 154: 145–149 Hammerer P, Hubner D, Gonnermann D, Huland H (1995) Peri-und postoperative Komplikationen der pelvinen Lymphadenektomie nach radikaler Prostatektomie an 320 konsekutiven Patienten. Urologe [A] 34: 334–342 Humphrey PA, Keetch DW, Smith DS, Shepherd DL, Catalona WJ (1996) Prospective characterization of pathological features of prostatic carcinoma detected via serum prostate specific antigen based screening. J Urol 155: 816–820 Johansson JE, Adami HO, Andersson SO, Bergström R, Holmberg L, Krusemo UB (1992) High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA 267: 2191–2196 Kleinschmidt K, Vieweg J, Gottfried HW, Miller K, Hautmann R (1991) Intra-und postoperative Morbidität der radikalen Prostatektomie. Urologe [A] 30: 387–393 Leach GE, Cooper F, Kagan R, Snyder R, Forsythe A (1982) Radiotherapy for prostatic carcinoma: post-irradiation prostatic biopsy and recurrence patterns with long-term followup. J Urol 128: 505–509 Leandri P, Rossignol G, Gautier JR, Ramon J (1992) Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol 147: 883–887 Lerner SE, Blute ML, Zincke H (1995) Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity. J Urol 154: 1447–1452 Manseck A, Wirth M (1997) Clinical value of prostate-specific antigen-detected prostate carcinoma (Stage T1c). Onkologie 20: 306–309 Middleton RG, Thompson MS, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, Miller HC, Oesterling JE, Mesnick MI, Smalley SR, Wasson JH (1995) Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J Urol 154: 2144–2148 Morgan WM, Bergstralh EJ, Zincke H (1993) Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer. Urology 41: 113–120 Murphy MP, Mettlin C, Menck H, Winchester DP, Davidson AM (1994) National patterns of prostate cancer treatment of radical prostatectomy results of a survey by the American College of Surgeons Commission on Cancer. J Urol 152: 1817–1819 NCI (1997) SEER Cancer statistics review 1973–1994. National Cancer Institute Oesterling JE, Suman VJ, Zincke H, Bostwick DG (1993) PSA-detected (clinical stage T1c or B0) prostate cancer. Urol Clin North Am 20: 687–693 Ohori M, Goad JR, Wheeler TM, Eastham JA, Thompson TC, Scardino PT (1994) Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 152: 1843–1849 Partin AW, Borland RN, Epstein JI, Brendler CB (1993) Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. J Urol 150: 142–146 Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional up-date. JAMA 277: 1445–1451 Partin AW, Lee BR, Carmichael M, Walsh PC, Epstein JL (1994) Radical prostatectomy for high grade disease: a reevaluation 1994. J Urol 151: 1583–1586 Paulson DF, Lin GH, Hinshaw W, Stephani S (1982) Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 128: 502–504 Paulson DF, Moul JW, Walther PJ (1990) Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long term results. J Urol 144: 1180–1184 Rosen MA, Goldstone L, Lapin S, Wheeler T, Scardino P (1992) Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. J Urol 148: 331–337 Rossetti SR, Terrone C (1996) Quality of life in prostate cancer patients. Eur Urol 30 [Suppl 1]: 44–48 Rossignol G, Leandri P, Ramon J, Gautier JR (1992) Radical prostatectomy in the management of stage A carcinoma of the prostate. Eur Urol 21: 269–273 Smith DS, Catalona WJ (1994) The nature of prostate cancer detected through prostate specific antigen-based screening. J Urol 152: 1732 Steiner M, Morton RA, Walsh PC (1991) Impact of anatomical radical prostatectomy on urinary continence. J Urol 145: 512–514 Steiner MS (1995) Current results and patient selection for nerve sparing radical retropubic prostatectomy. Semin Urol Oncol 13: 204–214 Stormont TJ, Farrow GM, Myers RP, Blute ML, Zincke H, Wilson TM, Oesterling JE (1993) Clinical stage BO or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration. Urology 41: 3–8 Syndikus I, Pickles T, Kostashuk E, Sullivan LD (1996) Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. J Urol 155: 1983–1986 Thompson JM, Paradelo JC, Crawford ED, Coltman CA, Blumenstein B (1994) An opportunity to determine optimal treatment of pT3 prostate cancer: the window may be closing. Urology 44: 804–811 Van den Ouden D, Davidson PJ, Hop W, Schroder FH (1994) Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer. J Urol 151: 646–651 Walsh PC, Partin AW, Epstein JI (1994) Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 152: 1831–1836 Whittemore A (1994) Prostate cancer: trends in cancer incidence and mortality. Cancer Surv 19/20: 309 Zagars GK, Von Eschenbach AC, Johnson DE, Oswald MJ (1987) Stage C adenocarcinoma of the prostate: an analysis of 551 patients treated with external beam radiation. Cancer 60: 1489–1499 Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM (1994) Longterm (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 152: 1850–1857 Zincke H, Utz DC, Taylor WF (1986) Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression. J Urol 135: 1199–1205